HUP9802736A3 - Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls - Google Patents
Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial wallsInfo
- Publication number
- HUP9802736A3 HUP9802736A3 HU9802736A HUP9802736A HUP9802736A3 HU P9802736 A3 HUP9802736 A3 HU P9802736A3 HU 9802736 A HU9802736 A HU 9802736A HU P9802736 A HUP9802736 A HU P9802736A HU P9802736 A3 HUP9802736 A3 HU P9802736A3
- Authority
- HU
- Hungary
- Prior art keywords
- medicament
- therapy
- prevention
- preparation
- arterial walls
- Prior art date
Links
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title 1
- 230000003143 atherosclerotic effect Effects 0.000 title 1
- 230000015556 catabolic process Effects 0.000 title 1
- 238000006731 degradation reaction Methods 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI951513A IT1275532B (it) | 1995-07-14 | 1995-07-14 | Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9802736A2 HUP9802736A2 (hu) | 1999-03-29 |
| HUP9802736A3 true HUP9802736A3 (en) | 2000-03-28 |
Family
ID=11371972
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9802736A HUP9802736A3 (en) | 1995-07-14 | 1996-06-28 | Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0839036B1 (hu) |
| JP (1) | JPH11509214A (hu) |
| KR (1) | KR19990028741A (hu) |
| CN (1) | CN1190345A (hu) |
| AT (1) | ATE183644T1 (hu) |
| AU (1) | AU690471B2 (hu) |
| CA (1) | CA2219501A1 (hu) |
| CZ (1) | CZ11698A3 (hu) |
| DE (1) | DE69603968T2 (hu) |
| DK (1) | DK0839036T3 (hu) |
| ES (1) | ES2138359T3 (hu) |
| GR (1) | GR3031096T3 (hu) |
| HU (1) | HUP9802736A3 (hu) |
| IL (1) | IL122302A (hu) |
| IT (1) | IT1275532B (hu) |
| NO (1) | NO980171D0 (hu) |
| SK (1) | SK4198A3 (hu) |
| WO (1) | WO1997003669A1 (hu) |
| ZA (1) | ZA965924B (hu) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20011726A1 (it) * | 2001-08-06 | 2003-02-06 | Recordati Ind Chimica E Farma | Forme polimorfe della lercanidipina cloridrato |
| US6852737B2 (en) | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
| TW200613275A (en) | 2004-08-24 | 2006-05-01 | Recordati Ireland Ltd | Lercanidipine salts |
| AR053023A1 (es) * | 2005-02-25 | 2007-04-18 | Recordati Ireland Ltd | Base libre de lercanidipina, metodos para su preparacion y composiciones farmaceuticas que las contienen |
| EP2585051B2 (en) | 2010-06-23 | 2020-04-08 | KRKA, tovarna zdravil, d.d., Novo mesto | Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts |
| US10010537B2 (en) | 2010-10-12 | 2018-07-03 | Chiesi Farmaceutici S.P.A. | Clevidipine emulsion formulations containing antimicrobial agents |
| US8658676B2 (en) | 2010-10-12 | 2014-02-25 | The Medicines Company | Clevidipine emulsion formulations containing antimicrobial agents |
| EP2654729B1 (en) | 2010-12-24 | 2016-05-04 | KRKA, d.d., Novo mesto | Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
-
1995
- 1995-07-14 IT ITMI951513A patent/IT1275532B/it active IP Right Grant
-
1996
- 1996-06-28 CN CN96195439A patent/CN1190345A/zh active Pending
- 1996-06-28 CA CA002219501A patent/CA2219501A1/en not_active Abandoned
- 1996-06-28 JP JP9506222A patent/JPH11509214A/ja active Pending
- 1996-06-28 IL IL12230296A patent/IL122302A/xx not_active IP Right Cessation
- 1996-06-28 KR KR1019980700039A patent/KR19990028741A/ko not_active Application Discontinuation
- 1996-06-28 AU AU65164/96A patent/AU690471B2/en not_active Ceased
- 1996-06-28 AT AT96924834T patent/ATE183644T1/de not_active IP Right Cessation
- 1996-06-28 SK SK41-98A patent/SK4198A3/sk unknown
- 1996-06-28 DE DE69603968T patent/DE69603968T2/de not_active Expired - Fee Related
- 1996-06-28 CZ CZ98116A patent/CZ11698A3/cs unknown
- 1996-06-28 HU HU9802736A patent/HUP9802736A3/hu unknown
- 1996-06-28 WO PCT/EP1996/002872 patent/WO1997003669A1/en not_active Application Discontinuation
- 1996-06-28 EP EP96924834A patent/EP0839036B1/en not_active Expired - Lifetime
- 1996-06-28 DK DK96924834T patent/DK0839036T3/da active
- 1996-06-28 ES ES96924834T patent/ES2138359T3/es not_active Expired - Lifetime
- 1996-07-12 ZA ZA965924A patent/ZA965924B/xx unknown
-
1998
- 1998-01-14 NO NO980171A patent/NO980171D0/no not_active Application Discontinuation
-
1999
- 1999-08-26 GR GR990402179T patent/GR3031096T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SK4198A3 (en) | 1998-05-06 |
| DK0839036T3 (da) | 2000-01-24 |
| AU6516496A (en) | 1997-02-18 |
| WO1997003669A1 (en) | 1997-02-06 |
| KR19990028741A (ko) | 1999-04-15 |
| EP0839036A1 (en) | 1998-05-06 |
| ITMI951513A0 (it) | 1995-07-14 |
| NO980171L (no) | 1998-01-14 |
| AU690471B2 (en) | 1998-04-23 |
| DE69603968T2 (de) | 2000-04-06 |
| IL122302A (en) | 2000-08-13 |
| ITMI951513A1 (it) | 1997-01-14 |
| NO980171D0 (no) | 1998-01-14 |
| EP0839036B1 (en) | 1999-08-25 |
| GR3031096T3 (en) | 1999-12-31 |
| IL122302A0 (en) | 1998-04-05 |
| ES2138359T3 (es) | 2000-01-01 |
| DE69603968D1 (de) | 1999-09-30 |
| ZA965924B (en) | 1997-01-30 |
| CZ11698A3 (cs) | 1998-06-17 |
| CA2219501A1 (en) | 1997-02-06 |
| ATE183644T1 (de) | 1999-09-15 |
| HUP9802736A2 (hu) | 1999-03-29 |
| JPH11509214A (ja) | 1999-08-17 |
| CN1190345A (zh) | 1998-08-12 |
| IT1275532B (it) | 1997-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9518115D0 (en) | Triazole derivatives and their use as therapeutic agents | |
| NZ321576A (en) | 6-imidazol-1-ylmethyl-2-oxo-quinoline derivatives and medicaments | |
| GB9515775D0 (en) | Piperidine derivatives and their use as therapeutic agents | |
| NZ329176A (en) | 2,5-dioxo-imidazolidine derivatives and medicaments | |
| AU5772196A (en) | 3,4-disubstituted-phenylsulphonamides and their therapeutic use | |
| GB2276639B (en) | Solutions for wood treatment and their preparation | |
| IL126900A0 (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
| AU5772296A (en) | 3,4-disubstituted-phenylsulphonamides and their therapeutic use | |
| AU5772396A (en) | 3,4-disubstituted-phenylsulphonamides and their therapeutic use | |
| HU9300880D0 (en) | Meethod for producing alkyl-diammonium-diclavulanate derivatives and medical preparatives | |
| NZ332309A (en) | Alkylamino-benzothiazole and -benzoxazole derivatives and medicaments | |
| KR100213963B1 (en) | Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis | |
| HUP0000963A3 (en) | The use of levobupivacaine in paediatric surgery | |
| HUP9802736A3 (en) | Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls | |
| PT879054E (pt) | Aplicação de derivados de pirrolidina na preparação de medicamentos para o tratamento do abuso de drogas | |
| GB9621419D0 (en) | 3-3-disubstituted piperidine derivatives and their use as therapeutic agents | |
| HK1016166A1 (en) | 5-naphthalen-1-yl-1, 3-dioxane derivatives, preparation and therapeutical use thereof | |
| AU3805895A (en) | Heterocyclylamino and heterocyclyloxy-cycloalkenyl derivatives and their use as pest-control agents and fungicides | |
| AU1801297A (en) | Spiro-ketal derivatives and their use as therapeutic agents | |
| GB9510223D0 (en) | Therapeutic agent | |
| GB9523066D0 (en) | Compounds and their therapeutic use | |
| GB9418550D0 (en) | Drug formulation | |
| IL130103A0 (en) | The use of a diarylalkane derivative in the manufacture of a medicament for treatment or prevention of pancreatitis | |
| ZA964518B (en) | Benzimidazole derivatives their preparation and their therapeutic use | |
| ZA953839B (en) | The administration of magnesium |